Diana Olusanmi is one of MaRS 21 Canadian tech entrepreneurs to watch in 2021

January 8, 2021

Diana Olusanmi moves the needle on fertility options

Despite all the developments made in reproductive science since the first “test tube” baby was born in 1978, there was still no test available to gauge the quality of a human egg. So Future Fertility, led by Diana Olusanmi, set out to change that. Her company offers AI-driven software that can calculate the health and reproductive likelihood of a human egg based on a 2D image. “There is a strong demand for greater transparency,” says Olusanmi. Since launching its first product this September, Future Fertility has heard from fertility clinics from all over the EU, Brazil, Malaysia and Japan.

What’s next: Future Fertility’s top priority for 2021 is to further refine the product and increase accuracy, which is currently 20 percent better than embryologists at predicting the likelihood of an egg becoming an embryo. The company is planning to close a Series A funding round in the first quarter of next year.

> See the article

Related posts

January 19, 2018

Fertility Dogma

AGE = EGG QUALITY Generally no individual oocyte feedback is given to patients Currently highly-trained embryologists visually assess morphology of [...]
February 19, 2019

Freezing Your Eggs Is Complicated, Expensive, And Might Not End With A Baby

Kate Durkin froze her eggs for the same reasons so many women freeze their eggs: she found herself single and [...]
December 11, 2017

AI and Deep Learning in Healthcare

Fields with biggest potential for AI in healthcare include: robot assisted surgery, nursing assistance, administrative workflow, clinical trials, preliminary and [...]